Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Innovate (VATE) over the last 16 years, with Q3 2025 value amounting to $13.0 million.

  • Innovate's Change in Accured Expenses rose 40000.0% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.7 million, marking a year-over-year increase of 25201.61%. This contributed to the annual value of $12.2 million for FY2024, which is 20892.86% up from last year.
  • Per Innovate's latest filing, its Change in Accured Expenses stood at $13.0 million for Q3 2025, which was up 40000.0% from $20.2 million recorded in Q2 2025.
  • Over the past 5 years, Innovate's Change in Accured Expenses peaked at $32.7 million during Q3 2021, and registered a low of -$27.9 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Accured Expenses was $1.8 million (2021), whereas its average is $1.0 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 49444.44% in 2022, then surged by 690000.0% in 2023.
  • Quarter analysis of 5 years shows Innovate's Change in Accured Expenses stood at $1.8 million in 2021, then tumbled by 494.44% to -$7.1 million in 2022, then crashed by 204.23% to -$21.6 million in 2023, then soared by 171.3% to $15.4 million in 2024, then decreased by 15.58% to $13.0 million in 2025.
  • Its Change in Accured Expenses was $13.0 million in Q3 2025, compared to $20.2 million in Q2 2025 and -$10.9 million in Q1 2025.